{"title":"抗真菌药物的最新发展趋势:配方、表征和应用参考","authors":"K. Pawar, R. Gadhave, Swati Waydande, P. Pawar","doi":"10.2174/2210303109666190508082009","DOIUrl":null,"url":null,"abstract":"\n\n Fungi are the heterotrophic eukaryotic organisms which are\nuseful as they causes the biodegradation. There are still some harmful species like yeasts, molds and dermatophytes\nwhich cause the infections. As the fungi are eukaryotics, they do not respond to the antibiotic\ntherapy due to the limitations associated with the traditional antibiotic therapies. There are several antifungal\nagents introduced to treat such infections. These antifungal agents posses severe problems like drug\nresistance and toxicity due to the higher dose which comprises the need for newer alternatives over\nconventional dosage forms. Novel drug delivery systems proved to be a better approach to enhance the\neffectiveness of the antifungals and enhance patient compliance by reducing the adverse effect.\n\n\n\nThis review focused on the general information about fungal infections, types and mechanism\nof action of antifungal agents and overview of formulation approaches such as vesicular system, colloidal\nsystem, nanoparticulate system and in situ gelling which are often studied for antifungal treatments.\n\n\n\nWe concluded that the novel drug delivery systems are the essential techniques for delivering\nthe antifungal agents to their target site with desired concentration. Moreover, the researchers focused\non these novel drug deliveries which mainly concentrate on controlling & sustaining the release\nof antifungal agents.\n","PeriodicalId":11310,"journal":{"name":"Drug Delivery Letters","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Recent Trends in Antifungal Agents: A Reference to Formulation, Characterization and Applications\",\"authors\":\"K. Pawar, R. Gadhave, Swati Waydande, P. Pawar\",\"doi\":\"10.2174/2210303109666190508082009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\n Fungi are the heterotrophic eukaryotic organisms which are\\nuseful as they causes the biodegradation. There are still some harmful species like yeasts, molds and dermatophytes\\nwhich cause the infections. As the fungi are eukaryotics, they do not respond to the antibiotic\\ntherapy due to the limitations associated with the traditional antibiotic therapies. There are several antifungal\\nagents introduced to treat such infections. These antifungal agents posses severe problems like drug\\nresistance and toxicity due to the higher dose which comprises the need for newer alternatives over\\nconventional dosage forms. Novel drug delivery systems proved to be a better approach to enhance the\\neffectiveness of the antifungals and enhance patient compliance by reducing the adverse effect.\\n\\n\\n\\nThis review focused on the general information about fungal infections, types and mechanism\\nof action of antifungal agents and overview of formulation approaches such as vesicular system, colloidal\\nsystem, nanoparticulate system and in situ gelling which are often studied for antifungal treatments.\\n\\n\\n\\nWe concluded that the novel drug delivery systems are the essential techniques for delivering\\nthe antifungal agents to their target site with desired concentration. Moreover, the researchers focused\\non these novel drug deliveries which mainly concentrate on controlling & sustaining the release\\nof antifungal agents.\\n\",\"PeriodicalId\":11310,\"journal\":{\"name\":\"Drug Delivery Letters\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Delivery Letters\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/2210303109666190508082009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2210303109666190508082009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Recent Trends in Antifungal Agents: A Reference to Formulation, Characterization and Applications
Fungi are the heterotrophic eukaryotic organisms which are
useful as they causes the biodegradation. There are still some harmful species like yeasts, molds and dermatophytes
which cause the infections. As the fungi are eukaryotics, they do not respond to the antibiotic
therapy due to the limitations associated with the traditional antibiotic therapies. There are several antifungal
agents introduced to treat such infections. These antifungal agents posses severe problems like drug
resistance and toxicity due to the higher dose which comprises the need for newer alternatives over
conventional dosage forms. Novel drug delivery systems proved to be a better approach to enhance the
effectiveness of the antifungals and enhance patient compliance by reducing the adverse effect.
This review focused on the general information about fungal infections, types and mechanism
of action of antifungal agents and overview of formulation approaches such as vesicular system, colloidal
system, nanoparticulate system and in situ gelling which are often studied for antifungal treatments.
We concluded that the novel drug delivery systems are the essential techniques for delivering
the antifungal agents to their target site with desired concentration. Moreover, the researchers focused
on these novel drug deliveries which mainly concentrate on controlling & sustaining the release
of antifungal agents.